TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...

Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...

Researchers in France and Japan have transmitted what they describe as the first DNA-encrypted message between laboratories, ...

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data Collaboration will expand ...

New Johns Hopkins research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...

The Katanga trial has been going on since 2024, and few cases in recent memory have gripped the country in the same way. From ...

Annual prizes from a Canadian foundation recognize the most significant advances in human biology and medicine ...

They Aim to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development ...

The 2026 Formula 1 rule changes are arguably the biggest in the history of grand prix racing, and certainly the most divisive ...

A wave of spatial transcriptomics studies has produced gene-expression atlases that span entire organs and whole organisms, ...